Intimation under Regulation 30 of SEBI (LODR) Regulation 2015 - "Issue of World Health Organisation (WHO) G.M.P Certificate
Vista Pharmaceuticals Ltd. Press Release Nov 14 2024
Filed with BSE ·
6ix hasn’t read this filing yet.
Vista Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Nov 13 2024
- Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vista Pharmaceuticals Ltd. Press Release Nov 07 2024
- Board Meeting Intimation for For Approval Of Unaudited Financial Results For The Quarter Ended 30.09.2024
Later from Vista Pharmaceuticals
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Dec 29 2024
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vista Pharmaceuticals Ltd. Press Release Jan 20 2025
- Board Meeting Intimation for Un Audited Financials Results For The Quarter Ended 31.12.2024
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals